Recurrent or refractory ptcl Clinical Trials
Conditions / Recurrent or refractory ptcl
Delta Trials records 1 clinical trial for Recurrent or refractory ptcl in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 19 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
19
Study Locations
Browse by location (19 total)
- Maebashi, Japan 1 trialAll trials in Maebashi, Japan
- Izumo, Japan 1 trialAll trials in Izumo, Japan
- Nagoya, Japan 1 trialAll trials in Nagoya, Japan
- Kyoto, Japan 1 trialAll trials in Kyoto, Japan
- Sendai, Japan 1 trialAll trials in Sendai, Japan
- Sapporo, Japan 1 trialAll trials in Sapporo, Japan
- Chūō, Japan 1 trialAll trials in Chūō, Japan
- Chūō, Japan 1 trialAll trials in Chūō, Japan
- Suita, Japan 1 trialAll trials in Suita, Japan
- Isehara, Japan 1 trialAll trials in Isehara, Japan
- Akashi, Japan 1 trialAll trials in Akashi, Japan
- Matsuyama, Japan 1 trialAll trials in Matsuyama, Japan
- Utsunomiya, Japan 1 trialAll trials in Utsunomiya, Japan
- Fukui, Japan 1 trialAll trials in Fukui, Japan
- Kumamoto, Japan 1 trialAll trials in Kumamoto, Japan
- Fukuoka, Japan 1 trialAll trials in Fukuoka, Japan
- Okayama, Japan 1 trialAll trials in Okayama, Japan
- Kagoshima, Japan 1 trialAll trials in Kagoshima, Japan
- Kotō, Japan 1 trialAll trials in Kotō, Japan
- Kotō, Japan 1 trialAll trials in Kotō, Japan